MedImmune LLC - Strategic SWOT Analysis Review

  • ID: 1291555
  • SWOT Analysis
  • 56 pages
  • GlobalData
  • Medimmune
1 of 5

FEATURED COMPANIES

  • bioCSL Inc
  • Eli Lilly and Co
  • Genentech Inc
  • GlaxoSmithKline Plc
  • ID Biomedical Corporation
  • Novartis AG
  • MORE
MedImmune LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights

MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting various diseases. Medimmune undertake research in the areas of cancer treatment; respiratory; inflammation and autoimmune; and cardiovascular disorders and metabolic diseases. It also develops vaccines for the prevention of infectious diseases. The company operates three R&D centers in Gaithersburg, Maryland; Cambridge, the UK; and Mountain View, California. MedImmune is headquartered in Gaithersburg, Maryland, the US.

MedImmune LLC Key Recent Developments

Jan 01, 2018: New Bio-Incubator and Life-Science Accelerator Capability Launches at the Babraham Research Campus
Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
Nov 08, 2017: AstraZeneca shares scientific updates from its extensive cardiovascular, renal and metabolic diseases (CVMD) portfolio at AHA 2017
Oct 16, 2017: AstraZeneca shares its comprehensive scientific approach at the World Conference on Lung Cancer 2017
Aug 31, 2017: AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • bioCSL Inc
  • Eli Lilly and Co
  • Genentech Inc
  • GlaxoSmithKline Plc
  • ID Biomedical Corporation
  • Novartis AG
  • MORE
Section 1 - About the Company
  • MedImmune LLC - Key Facts
  • MedImmune LLC - Key Employees
  • MedImmune LLC - Key Employee Biographies
  • MedImmune LLC - Major Products and Services
  • MedImmune LLC - History
  • MedImmune LLC - Company Statement
  • MedImmune LLC - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • MedImmune LLC - Business Description
  • MedImmune LLC - SWOT Analysis
  • SWOT Analysis - Overview
  • MedImmune LLC - Strengths
  • MedImmune LLC - Weaknesses
  • MedImmune LLC - Opportunities
  • MedImmune LLC - Threats
  • MedImmune LLC - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • MedImmune LLC, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Jan 01, 2018: New Bio-Incubator and Life-Science Accelerator Capability Launches at the Babraham Research Campus
  • Dec 01, 2017: Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
  • Nov 08, 2017: AstraZeneca shares scientific updates from its extensive cardiovascular, renal and metabolic diseases (CVMD) portfolio at AHA 2017
  • Oct 16, 2017: AstraZeneca shares its comprehensive scientific approach at the World Conference on Lung Cancer 2017
  • Aug 31, 2017: AstraZeneca highlights latest advances in lung cancer at the ESMO 2017 Congress
  • Jul 31, 2017: AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts31 July 2017
  • Jul 06, 2017: New Synthetic DNA-Based Strategy Shows Promise Against a Diverse Range of Influenza Viruses
  • May 26, 2017: AstraZeneca delivers new data on expanding portfolio of cancer medicines at 2017 American Society of Clinical Oncology Annual Meeting
  • May 18, 2017: AstraZeneca to present scientific advancements from growing respiratory portfolio at the American Thoracic Society conference 2017
Section 5 - Appendix
  • Methodology
  • About
  • Contact
  • Disclaimer
List of Tables
  • MedImmune LLC, Key Facts
  • MedImmune LLC, Key Employees
  • MedImmune LLC, Key Employee Biographies
  • MedImmune LLC, Major Products and Services
  • MedImmune LLC, History
  • MedImmune LLC, Other Locations
  • MedImmune LLC, Subsidiaries
  • MedImmune LLC, Key Competitors
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • MedImmune LLC, Recent Deals Summary
List of Figures
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • MedImmune LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Variation Biotechnologies Inc
  • Sernova Corp
  • Pfizer Vaccines LLC
  • Novartis Vaccines and Diagnostics Inc
  • Novartis AG
  • ID Biomedical Corporation
  • GlaxoSmithKline Plc
  • Genentech Inc
  • Eli Lilly and Co
  • bioCSL Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll